A8-G6

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameA8-G6
Drug Alias NameSARS-CoV-2 neutralizing antibody combination (The Second Affiliated Hospital of Chongqing Medical University)A8-G6
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesThe Second Affiliated Hospital Of Chongqing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe Second Affiliated Hospital Of Chongqing Medical University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A